EXAGEN INC. - Common Stock, par value $0.001 per share (XGN)

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
22,037,221
Total 13F shares
4,223,178
Share change
+184,213
Total reported value
$55,621,160
Price per share
$13.20
Number of holders
33
Value change
+$2,490,861
Number of buys
14
Number of sells
11

Institutional Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q4 2020

As of 31 Dec 2020, EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,223,178 shares. The largest 10 holders included RTW INVESTMENTS, LP, WASATCH ADVISORS INC, NOMURA HOLDINGS INC, COWEN AND COMPANY, LLC, VANGUARD GROUP INC, BlackRock Inc., PERKINS CAPITAL MANAGEMENT INC, Eversept Partners, LP, GEODE CAPITAL MANAGEMENT, LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC. This page lists 33 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.